Covetrus (CVET) Trading Down 1.7%
Covetrus Inc (NASDAQ:CVET) was down 1.7% during trading on Friday . The company traded as low as $25.68 and last traded at $25.39. Approximately 48,811 shares were traded during trading, a decline of 97% from the average daily volume of 1,541,107 shares. The stock had previously closed at $25.83.
A number of equities research analysts recently commented on CVET shares. Raymond James started coverage on Covetrus in a research note on Wednesday, February 27th. They set an “outperform” rating and a $45.00 price objective for the company. Stifel Nicolaus initiated coverage on shares of Covetrus in a research note on Wednesday. They issued a “hold” rating and a $30.00 price objective for the company. Svb Leerink reaffirmed an “outperform” rating on shares of Covetrus in a report on Wednesday, March 20th. Credit Suisse Group initiated coverage on shares of Covetrus in a report on Thursday, April 4th. They issued a “neutral” rating and a $35.00 target price on the stock. Finally, William Blair initiated coverage on shares of Covetrus in a report on Tuesday, February 12th. They issued an “outperform” rating on the stock. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and three have given a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus target price of $36.67.
The company has a debt-to-equity ratio of 0.51, a current ratio of 1.82 and a quick ratio of 0.93.
In other news, Director Betsy S. Atkins sold 150,845 shares of Covetrus stock in a transaction on Friday, May 17th. The shares were sold at an average price of $27.80, for a total value of $4,193,491.00. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, insider Timothy Ludlow sold 81,498 shares of Covetrus stock in a transaction on Friday, May 17th. The shares were sold at an average price of $28.01, for a total transaction of $2,282,758.98. The disclosure for this sale can be found here. Insiders sold a total of 233,028 shares of company stock worth $6,495,656 over the last ninety days.
About Covetrus (NASDAQ:CVET)
Covetrus, Inc engages in developing technologies and services for animal health industry. It also provides products, software, and services to help drive improved patient health, strong client relationships, and successful financial outcomes for veterinary professionals. The company was founded on April 13, 2018 and is headquartered in Melville, NY.
Featured Article: Growth and Income Funds
Receive News & Ratings for Covetrus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Covetrus and related companies with MarketBeat.com's FREE daily email newsletter.